Fibrinolysis and cardiovascular risk factors: Association with fibrinogen, lipids, and monocyte count

European Journal of Internal Medicine

Volumn 17, Issue 2, 2006, Pages 102-108

  Zouaoui Boudjeltia, Karim ^a   Guillaume, Michel ^b   Henuzet, Charles ^b   Delrée, Paul ^c   Cauchie, Philippe ^a   Remacle, Claude ^d   Ducobu, Jean ^e   Vanhaeverbeek, Michel ^a   Brohée, Dany ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b CHU Andre Vesale   (Belgium)

^c Pathology and Genetics Institute   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e Centre Hospitalier Universitaire de Tivoli   (Belgium)

Author keywords

Atherosclerosis; Cardiovascular risk; ECLT; Endothelium dysfunction; Fibrinolysis; Framingham; Monocytes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; HUMAN; LEUKOCYTE COUNT; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33144464451     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.11.002     Document Type: Article

References (39)

1. M. Pahor, M.B. Elam, R.J. Garrison, S.B. Kritchevsky, and W.B. Applegate Emerging noninvasive biochemical measures to predict cardiovascular risk Arch Intern Med 159 1999 237 245
2. V. Salomaa, V. Stinson, J.D. Kark, A.R. Folsom, C.E. Davis, and K.K. Wu Association of fibrinolytic parameters with early atherosclerosis, the ARIC study Circulation 91 1995 284 290
3. S.G. Thompson, J. Kienast, S.D. Pyke, F. Haverkate, and J.C. Van Loo Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on thrombosis and Disabilities Angina Pectoris Study Group N Engl J Med 332 1995 635 641
4. J.D. Pearson The control of production and release of haemostatic factors in the endothelial cell Baillieres Clin Haematol 6 1993 629 651
5. H. Tomiyama, Y. Kimura, H. Mitsuhashi, T. Kinouchi, H. Yoshida, and T. Kushiro Relationship between endothelial function and fibrinolysis in early hypertension Hypertension 31 1998 321 327
6. P. Poderos Endothelial dysfunction in the pathogenesis of atherosclerosis Int Angiol 21 2002 109 116
7. M.M. Cerinic, G. Valentini, and G.G. Sorano Blood coagulation, fibrinolysis and markers of endothelial dysfunction in systemic sclerosis Semin Arthritis Rheum 32 2003 285 295
8. E.G. Nabel, A.P. Selwyn, and P. Ganz Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis J Am Coll Cardiol 16 1990 349 356
9. D.S. Celermajer, K.E. Sorensen, C. Bull, J. Robinson, and J.E. Deanfield Endothelium dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction J Am Coll Cardiol 24 1994 1468 1474
10. D.C. Felmeden, G.C. Spencer, A.D. Blann, D.G. Beevers, and G. Lip Low-density lipoprotein subfractions and cardiovascular risk in hypertension. Relationship to endothelial dysfunction and effects of treatment Hypertension 41 2003 528 533
11. D.W. Brown, W.H. Giles, and J.B. Croft White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort J Clin Epidemiol 54 2001 316 322
12. G.D. Friedman, A.L. Klatsky, and A.G. Siegelaub The leukocyte count as a predictor of myocardial infarction N Engl J Med 290 1974 1275 1278
13. M. Haim, V. Boyko, U. Goldbourt, A. Battler, and S. Behar Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease Arch Intern Med 164 2004 433 439
14. R.E. Gerszeten, F. Mach, A. Sauty, A. Rosenweig, and A.D. Luster Chemokines, leukocytes and atherosclerosis J Lab Clin Med 136 2000 87 92
15. R. Olivares, P. Ducimetiere, and J.R. Claude Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 137 1993 49 53
16. J. Jespersen, R.M. Bertina, and F. Haverkate Ecat Assay Procedures; A Manual of Laboratory Techniques 1992 Kluwer Dordrecht 125 129
17. K. Zouaoui Boudjeltia, P. Cauchie, C. Remacle, M. Guillaume, D. Brohee, and J.L. Hubert A new device for measurement of fibrin clot lysis: application to Euglobulin Clot Lysis Time BMC Biotechnol 2 2002 8
18. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cuchman, L.A. Green, and J.L. Izzo The seventh Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report JAMA 289 2003 2560 2572
19. G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, and J. Dallongeville European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts Eur J Cardiovasc Prev Rehabil Suppl. 1 2003 S1 S78
20. A.M. Dart, and J.P. Chin-Dusting Lipids and endothelium Cardiovasc Res 43 1999 308 322
21. H. Funayama, Y. Sakata, S. Kitagawa, U. Ikeda, M. Takahashi, and J. Masuyama Monocytes modulate the fibrinolytic balance of endothelial cells Thromb Res 85 1997 377 385
22. S.P. Ballou, and G. Lozanski Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein Cytokine 4 1992 361 368
23. R.L. Whisler, V.K. Proctor, E.C. Downs, and R.F. Mortensen Modulation of human monocyte chemotaxis and procoagulant activity by human C-reactive protein Lymphokine Res 5 1986 223 227
24. T. Lund, and B. Østerud Fibrinogen increases lipopolysaccharide- induced tumor necrosis factor-α and interleukin-8 release, and enhances tissue factor activity in monocytes in a modified whole blood system Blood Coagul Fibrinolysis 12 2001 667 675
25. R.G. Sitrin, P.M. Pan, S. Srikanth, and R.F. Todd Fibrinogen activates NF-κB transcription factors in mononuclear phagocytes J Immunol 161 1998 1462 1470
26. G. Rothe, H. Gabriel, E. Kovacs, J. Klucken, J. Sthor, and W. Kindermann Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia Arterioscler Thromb Vasc Biol 16 1996 1437 1447
27. K.-U. Belge, F. Dayyani, and A. Horelt The proinflammatory CD14+ CD16+ DR++ monocytes are major source of TNF The Journal of Immunology 168 2002 3536 3542
28. P.M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813 1818
29. S. Devaraj, D.Y. Xu, and I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis Circulation 107 2003 398 404
30. R.J. Bisoendial, J.J. Kastelein, J.H.M. Levels, J.J. Zwaginga, B. Van den Bogaard, and P.H. Reitsma Activation of inflammation and coagulation after infusion of C-reactive protein in humans Circ Res 17 2005
31. K. Zouaoui Boudjeltia, M. Piagnerelli, D. Brohee, M. Guillaume, P. Cauchie, and J.L. Vincent Relationship between CRP and hypofibrinolysis: it is a possible mechanism to explain the association between CRP and outcome in critically ill patients? Thrombosis Journal 2 2004 7
32. G.A. Rosito, R.B. D'agostino, and J. Massaro Association between obesity and a prothrombotic state: the Framinghma Offspring study Thromb Haemost 91 2004 683 689
33. C.H. Lundgren, S.L. Brown, and T.K. Nordt Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential link between obesity and cardiovascular disease Circulation 93 1996 106 110
34. M.C. Alessi, D. Bastelica, and A. Mavri Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation Arterioscler Thromb Vasc Biol 23 2003 1262 1268
35. R. Rocha, H.P. Cotrim, F.M. Carvalho, A.C. Siqueira, H. Braga, and LA. Freitas Body mass index and waist circumference in non-alcoholic fatty liver disease J Hum Nutr Diet 18 2005 365 370
36. I.S. Jovin, and G. Müller-Berghaus Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis Atherosclerosis 174 2004 225 233
37. A.R. Folsom Fibrinolytic factors and atherothrombotic events: epidemiological evidence Ann Med 32 Suppl. 1 2000 85 91
38. D.B. Cines, E.S. Pollak, C.A. Buck, J. Losclazo, G.A. Zimmerman, and R.P. Mc Ever Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561
39. R. De Caterina Endothelial dysfunctions: common denominators in vascular disease Curr Opin Clin Nutr Metab Care 3 2000 453 467